Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Nakamura

Showing results (251-260 of 709) with videos related to

Pageof 71
Sort By:
Revista Espanola De Cardiologia (English Ed.)|August 27, 2014
SYNTAX score predicts major bleeding following drug-eluting stent implantation in an all-comers populationRaisuke Iijima, Yoshinori Nagashima, Kaori Sato, et al.
World Journal of Hepatology|February 4, 2016
Sofosbuvir treatment and hepatitis C virus infectionMasato Nakamura, Tatsuo Kanda, Yuki Haga, et al.
Anticancer Research|June 30, 2016
Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX TrialTakanori Matsui, Naoki Nagata, Keiji Hirata, et al.
Cardiovascular Intervention and Therapeutics|January 19, 2017
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studiesMasakatsu Nishikawa, Takaaki Isshiki, Takeshi Kimura, et al.
Case Reports in Oncology|June 14, 2014
Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected PatientsTatsuo Kanda, Shingo Nakamoto, Shin Yasui, et al.
International Journal of Cardiology|February 14, 2015
Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS studyMasato Nakamura, Takaaki Isshiki, Takeshi Kimura, et al.
Journal of Cardiology|January 25, 2020
The impact of sleep apnea on right atrial structural remodeling with atrial fibrillationTakahito Takagi, Keijiro Nakamura, Hikari Hashimoto, et al.
Cardiovascular Intervention and Therapeutics|August 2, 2022
Two-year results of endovascular therapy for femoropopliteal artery disease in Japan during the introduction of drug-eluting devicesKenji Suzuki, Daisuke Ueshima, Michiaki Higashitani, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2006
Independent risk factors for progression of coronary atherosclerosis in hemodialysis patientsHiroki Hase, Nobuhiko Joki, Hiroyasu Ishikawa, et al.
International Journal of Oncology|January 15, 2002
Human thrombospondin 2 inhibits proliferation of microvascular endothelial cellsYasushi Tomii, Junichiro Kamochi, Hitoshi Yamazaki, et al.
Pageof 71

Showing results (251-260 of 709) with videos related to

Sort By:
Pageof 71
Revista Espanola De Cardiologia (English Ed.)|August 27, 2014
SYNTAX score predicts major bleeding following drug-eluting stent implantation in an all-comers populationRaisuke Iijima, Yoshinori Nagashima, Kaori Sato, et al.
World Journal of Hepatology|February 4, 2016
Sofosbuvir treatment and hepatitis C virus infectionMasato Nakamura, Tatsuo Kanda, Yuki Haga, et al.
Anticancer Research|June 30, 2016
Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX TrialTakanori Matsui, Naoki Nagata, Keiji Hirata, et al.
Cardiovascular Intervention and Therapeutics|January 19, 2017
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studiesMasakatsu Nishikawa, Takaaki Isshiki, Takeshi Kimura, et al.
Case Reports in Oncology|June 14, 2014
Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected PatientsTatsuo Kanda, Shingo Nakamoto, Shin Yasui, et al.
International Journal of Cardiology|February 14, 2015
Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS studyMasato Nakamura, Takaaki Isshiki, Takeshi Kimura, et al.
Journal of Cardiology|January 25, 2020
The impact of sleep apnea on right atrial structural remodeling with atrial fibrillationTakahito Takagi, Keijiro Nakamura, Hikari Hashimoto, et al.
Cardiovascular Intervention and Therapeutics|August 2, 2022
Two-year results of endovascular therapy for femoropopliteal artery disease in Japan during the introduction of drug-eluting devicesKenji Suzuki, Daisuke Ueshima, Michiaki Higashitani, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 17, 2006
Independent risk factors for progression of coronary atherosclerosis in hemodialysis patientsHiroki Hase, Nobuhiko Joki, Hiroyasu Ishikawa, et al.
International Journal of Oncology|January 15, 2002
Human thrombospondin 2 inhibits proliferation of microvascular endothelial cellsYasushi Tomii, Junichiro Kamochi, Hitoshi Yamazaki, et al.
Pageof 71